Regentis Biomaterials RGNT
NYSE RGNT
$1.85 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:36 PM EDT

Regentis Biomaterials (RGNT) Total Non-Current Liabilities (2024)

Updated

Regentis Biomaterials' Total Non-Current Liabilities was $41.43 million in Q4 2024.

Analysis

Regentis Biomaterials (RGNT) Total Non-Current Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 55.95 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn -
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 33.25 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 40.46 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 21.28 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 17.56 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 2.57 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 23.92 Bn
10 Regentis Biomaterials 1.08 Mn -7.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 41.43 Mn
API Access

Regentis Biomaterials Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNT&period=max&api_key=YOUR_API_KEY